Literature DB >> 20370816

Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency.

Bernhard Schmitt1, Matthias Baumgartner, Philippa B Mills, Peter T Clayton, Cornelis Jakobs, Elmar Keller, Gabriele Wohlrab.   

Abstract

AIM: We report on seizures, paroxysmal events, and electroencephalogram (EEG) findings in four female infants with pyridoxine-dependent epilepsy (PDE) and in one female with pyridoxine phosphate oxidase deficiency (PNPO).
METHOD: Videos and EEGs were analysed and compared with videos of seizures and paroxysmal events archived from 140 neonates. PDE and PNPO were proven by complete control of seizures once pyridoxine or pyridoxal 5'-phosphate was administered and by recurrence when withdrawn. Mutations in the antiquitin gene were found in three patients and in the PNPO gene in one child.
RESULTS: Seizures began within 48 hours after birth in four newborns and at age 3 weeks in one. Frequent multifocal and generalized myoclonic jerks, often intermixed with tonic symptoms, abnormal eye movement, grimacing, or irritability, were observed in all infants with PDE and PNPO, but rarely in the other archived videos of neonates. EEGs were inconstant and frequently no discernable ictal changes were recorded during the seizures and the paroxysmal events. In addition, interictal EEGs were inconclusive, with normal and abnormal recordings. In older children tonic-clonic seizures, abnormal behaviour, inconsolable crying, frightened facial expression, sleep disturbance, loss of consciousness, paraesthesia, or intermittent visual symptoms were described during controlled and uncontrolled withdrawal or insufficient dosage.
INTERPRETATION: PDE or PNPO should be considered in infants with prolonged episodes of mixed multifocal myoclonic tonic symptoms, notably when associated with grimacing and abnormal eye movements.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20370816     DOI: 10.1111/j.1469-8749.2010.03660.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  26 in total

Review 1.  Early-onset epileptic encephalopathies and the diagnostic approach to underlying causes.

Authors:  Su-Kyeong Hwang; Soonhak Kwon
Journal:  Korean J Pediatr       Date:  2015-11-22

2.  Partial Pyridoxine Responsiveness in PNPO Deficiency.

Authors:  Phillip L Pearl; Keith Hyland; J Chiles; Colleen L McGavin; Yuezhou Yu; Donald Taylor
Journal:  JIMD Rep       Date:  2012-11-07

3.  Long-Term Follow-up of a Successfully Treated Case of Congenital Pyridoxine-Dependent Epilepsy.

Authors:  Malcolm Proudfoot; Philip Jardine; Agne Straukiene; Rupert Noad; Andrew Parrish; Sian Ellard; Stuart Weatherby
Journal:  JIMD Rep       Date:  2013-02-12

4.  Pyridoxine-dependent epilepsies: an observational study on clinical, diagnostic, therapeutic and prognostic features in a pediatric cohort.

Authors:  Raffaele Falsaperla; Maria Stella Vari; Irene Toldo; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Agnese Suppiej; Alberto Burlina; Mario Mastrangelo; Vincenzo Leuzzi; Valentina Marchiani; Paola De Liso; Giuseppe Capovilla; Pasquale Striano; Giovanna Vitaliti
Journal:  Metab Brain Dis       Date:  2017-11-25       Impact factor: 3.584

5.  Cirrhosis associated with pyridoxal 5'-phosphate treatment of pyridoxamine 5'-phosphate oxidase deficiency.

Authors:  Annapurna Sudarsanam; Harry Singh; Bridget Wilcken; Michael Stormon; Susan Arbuckle; Bernhard Schmitt; Peter Clayton; John Earl; Richard Webster
Journal:  JIMD Rep       Date:  2014-09-26

6.  The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1.

Authors:  Gunter Scharer; Chad Brocker; Vasilis Vasiliou; Geralyn Creadon-Swindell; Renata C Gallagher; Elaine Spector; Johan L K Van Hove
Journal:  J Inherit Metab Dis       Date:  2010-09-03       Impact factor: 4.982

7.  PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?

Authors:  D Coman; P Lewindon; P Clayton; K Riney
Journal:  JIMD Rep       Date:  2015-06-25

8.  Normal Cerebrospinal Fluid Pyridoxal 5'-Phosphate Level in a PNPO-Deficient Patient with Neonatal-Onset Epileptic Encephalopathy.

Authors:  Alina Levtova; Stephane Camuzeaux; Anne-Marie Laberge; Pierre Allard; Catherine Brunel-Guitton; Paola Diadori; Elsa Rossignol; Keith Hyland; Peter T Clayton; Philippa B Mills; Grant A Mitchell
Journal:  JIMD Rep       Date:  2015-03-12

9.  Pyridoxine responsiveness in novel mutations of the PNPO gene.

Authors:  Barbara Plecko; Karl Paul; Philippa Mills; Peter Clayton; Eduard Paschke; Oliver Maier; Oswald Hasselmann; Gudrun Schmiedel; Simone Kanz; Mary Connolly; Nicole Wolf; Eduard Struys; Sylvia Stockler; Lucia Abela; Doris Hofer
Journal:  Neurology       Date:  2014-03-21       Impact factor: 9.910

Review 10.  Clinical management of seizures in newborns : diagnosis and treatment.

Authors:  Linda G M van Rooij; Marcel P H van den Broek; Carin M A Rademaker; Linda S de Vries
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.